Gastric Malignancy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Phathom Pharma (PHAT) Announces FDA Acceptance for Filing of VOQUEZNA Tablets NDA for Treatment of Heartburn Associated with Non-Erosive GERD

Phathom Pharma (PHAT) Announces FDA Acceptance for Filing of VOQUEZNA Tablets NDA for Treatment of Heartburn Associated with Non-Erosive GERD
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Azmi nabulsiPhathom pharmaceuticals incPhathom pharmaceuticalsPrescription drug user fee actNew drug applicationChief operating officerErosive esophagitisErosive gastroesophageal reflux diseaseGastric malignancyTubulointerstitial nephritisAssociated diarrheaCutaneous adverse reactionsMineral metabolismDiagnostic investigationsNeuroendocrine tumorsGland polyps

Endo International plc: Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant®

DUBLIN, June 15, 2023 /PRNewswire/ Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping dexlansoprazole 30

Scott simsTakeda dexilantTakeda pharmaceuticals united statesa incInjectable solutions generics at endoPrnewswire endo internationalExchange commissionPar pharmaceuticalSenior vice presidentGeneral managerInjectable solutionsTakeda pharmaceuticals united statesaDelayed release capsulesGastric malignancyTubulointerstitial nephritisAssociated diarrheaCutaneous adverse reactions

Endo International (ENDPQ) Launches Dexlansoprazole Capsules, Generic Version of Dexilant

Endo International (ENDPQ) Launches Dexlansoprazole Capsules, Generic Version of Dexilant
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Scott simsTakeda dexilantEndo internationalInjectable solutions generics at endoTakeda pharmaceuticals united statesa incPar pharmaceuticalSenior vice presidentGeneral managerInjectable solutionsTakeda pharmaceuticals united statesaDelayed release capsulesGastric malignancyTubulointerstitial nephritisAssociated diarrheaCutaneous adverse reactionsSystemic lupus erythematosus

Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant®

/PRNewswire/ Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping.

Scott simsTakeda dexilantPrnewswire endo internationalExchange commissionInjectable solutions generics at endoEndo internationalTakeda pharmaceuticals united statesa incPar pharmaceuticalSenior vice presidentGeneral managerInjectable solutionsTakeda pharmaceuticals united statesaDelayed release capsulesGastric malignancyTubulointerstitial nephritisAssociated diarrhea